The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
E
|
Elevance Health Inc
F:A58
|
US |
|
Zurich Insurance Group AG
F:ZFIN
|
CH |
|
Site Centers Corp
F:DDR
|
US |
|
B
|
Banco Santander SA
XMUN:BSD2
|
ES |
|
P
|
Ponce Financial Group Inc
F:73V0
|
US |
|
M
|
Moody's Corp
XMUN:DUT
|
US |
|
P
|
Paccar Inc
XMUN:PAE
|
US |
|
S
|
Silvercorp Metals Inc
XMUN:S9Y
|
CA |
|
A
|
ACS Actividades de Construccion y Servicios SA
XMUN:OCI1
|
ES |
|
K
|
Kirin Holdings Co Ltd
OTC:KNBWF
|
JP |
|
Tsingtao Brewery Co Ltd
F:TSI0
|
CN |
|
L
|
Lloyds Banking Group PLC
F:LLD2
|
UK |
|
C
|
CITIC Securities Co Ltd
SWB:CI9
|
CN |
|
Corcept Therapeutics Inc
NASDAQ:CORT
|
US |
|
M
|
Mohawk Industries Inc
F:MWK
|
US |
|
Aeroports de Paris SA
PAR:ADP
|
FR |
|
Gap Inc
NYSE:GAP
|
US |
|
D
|
Dentsu Group Inc
DUS:DEN
|
JP |
|
Sands China Ltd
F:599A
|
MO |
|
B
|
Brown & Brown Inc
XMUN:BTW
|
US |
|
P
|
Pultegroup Inc
BMV:PHM
|
US |
|
Y
|
Yara International ASA
XMUN:IU2
|
NO |
|
S
|
Southwest Airlines Co
BMV:LUV
|
US |
|
L'Oreal SA
PAR:OR
|
FR |
Elevance Health Inc (A58)’s 12-month stock price forecast through September 2027 has a consensus target of €398, implying 14% upside. The forecast is based on price targets from 27 Wall Street analysts.
Past growth per year Not enough data
Average annual growth cannot be calculated for these periods.
Explore analyst estimates, growth and forecast ranges.
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
According to Wall Street analysts, the average 1-year price target for
A58 is 398 EUR with a low forecast of 339.65 EUR and a high forecast of 442.06 EUR.
Over the last 13 years, the compound annual growth rate for Revenue has been 9%. The projected CAGR for the next 5 years is 3%.
Over the last 13 years, the compound annual growth rate for Net Income has been 6%. The projected CAGR for the next 8 years is 8%.
AI-generated answers can contain mistakes, outdated facts, or incomplete information. Always verify important details before making decisions.
The AI Assistant is designed for research and education. It does not provide personalized investment, legal, or tax advice.
We rebuilt our DCF valuation models from the ground up and upgraded how Intrinsic Value is calculated. Alpha Spread now selects the method that best fits each company.
You can now see how the new methodology performed across thousands of stocks on our new Valuation Backtest page. We update the results at the end of every month.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
By using Alpha Spread you are agreeing to our Terms of Service and Privacy Policy.
Stock intrinsic value is the real worth of a company's stock, based on its financial health and performance.
Instead of looking at the stock's current market price, which can change due to people's opinions and emotions, intrinsic value helps us understand if a stock is truly a good deal or not.
By focusing on the company's actual financial strength, like its earnings and debts, we can make better decisions about which stocks to buy and when.
Read more